Survey of the rate of PSA testing in general practice

The use of prostate specific antigen (PSA) test could have a large impact on the incidence of prostate cancer in the UK. Over a period of 1 year (1999), 3.5% out of 160 015 men aged > 45 on a GP database, who had no previous record of prostate cancer, had a PSA test. Of the tested men, 21.3% had...

Descripción completa

Detalles Bibliográficos
Autores principales: Melia, J, Moss, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364127/
https://www.ncbi.nlm.nih.gov/pubmed/11531246
http://dx.doi.org/10.1054/bjoc.2001.1962
Descripción
Sumario:The use of prostate specific antigen (PSA) test could have a large impact on the incidence of prostate cancer in the UK. Over a period of 1 year (1999), 3.5% out of 160 015 men aged > 45 on a GP database, who had no previous record of prostate cancer, had a PSA test. Of the tested men, 21.3% had a PSA > 4 ng/ml. Future data need to distinguish between men with and without symptoms. © 2001 Cancer Research Campaign http://www.bjcancer.com

Ejemplares similares